Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Systemic corticosteroids might help treat hair loss caused by alemtuzumab in MS patients.

Lichen planopilaris can be triggered by prolonged scalp traction and can be treated with corticosteroids.

Alopecia areata after COVID-19 vaccination is rare but important to recognize for timely treatment.

New regenerative treatments for hair loss show promise but need more research for confirmation.

Skin side effects from cancer treatments can lead to changes in therapy and are common, with nail changes being the most frequent.

Satoyoshi syndrome is likely an autoimmune disease.

PRP shows promise for spinal pain but needs more guidelines before widespread use.

Rituximab may be an effective treatment for Cronkhite-Canada syndrome with kidney disease.

Control inflammation and prevent further hair loss in folliculitis decalvans using medications and therapies.

Methotrexate alone is as effective and safe as combining it with prednisolone for treating Lichen planopilaris.

Lichen simplex chronicus on the scalp can be diagnosed by specific hair and skin signs and treated with corticosteroids and therapy.

Methotrexate effectively controls eye inflammation in Japanese patients with non-infectious uveitis but requires careful monitoring for side effects.

Early treatment of Lupus Erythematosus Alopecia can prevent permanent hair loss, and various medications are effective.

General practitioners in Qassim have satisfactory knowledge of alopecia areata but need more education to address gaps and misconceptions.

Caffeine shows promise for treating some types of hair loss, but more research is needed.

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

A rare type of skin cancer with mucosal involvement was partially treated but eventually relapsed.

Kerion in Fars Province mainly affects boys under 11 linked to animal contact, with varied treatment outcomes.

Dermatology drug use in Denmark mostly follows expected patterns, but further checks are needed for any misuse.

Recognizing and treating oral lichen sclerosus is important, but treatment guidelines are lacking.

COVID-19 has widely affected health, various industries, and the economy, but also led to more remote work and less pollution.

New treatments focusing on immune pathways show promise for stubborn hair loss.

Apremilast shows promise for several skin conditions but needs more research.

The guideline recommends personalized treatment for alopecia areata, including new oral medications and psychological support.

A potential link exists between unexplained hormone deficiency, hair loss, and testicular tumors, suggesting thorough screening is needed.

SLE in Iraqi patients often involves hair loss and photosensitivity, with common treatments being corticosteroids and immunosuppressants.

Cronkhite-Canada syndrome is rare, has a poor prognosis, and requires early diagnosis and ongoing treatment.